PTSD Special Report, Part II: Promising Treatments and Emerging Opportunities
This is Part II of our special report on PTSD, a survey of the rising causes for concern and potential treatments to combat it.
This is Part II of our special report on PTSD, a survey of the rising causes for concern and potential treatments to combat it.
The 5th Annual Vaccine Industry Excellence Awards has named Advaxis as the Best Therapeutic Vaccine for the company’s ADVX-HPV construct.
In response to a recent press release from TONIX Pharmaceuticals, a leading company in the exploration of alternative PTSD treatment, we are issuing a 2-part special report looking at recent developments
In this unprecedented age of technology and communication, many wonder why the healthcare industry has traditionally not been on the cutting edge.
Reed Smith LLP, a global business law firm, recently issued a JOBS Act bulletin to its network. The bulletin, co-authored by seven partners on both coasts, summarizes and analyzes the JOBS Act.
Part Three of our Special Report analyzes what may be one of the first ‘test cases’ of the new patent infringement precedent.
Unlike technology, entertainment, retail and other sectors, novel medical technologies and therapeutics take years of pre-development, and require institutional manpower to further growth.
The Food and Drug Administration must act quickly to enforce a largely ignored 35-year-old mandate prohibiting non-medical use of antibiotics in farm animals.
Despite political contention over the influence of corporate America in shaping the American Dream, our nation’s leaders tend to unite in their respect of small business.
The OneMedResearch January/February 2012 Issue discusses the developments of several small companies with intriguing technology in an emerging market. The report contains full financial updates of […]
Copyright © 2024 | WordPress Theme by MH Themes